Skip to main content
SYRE logo

SYRE · Spyre Therapeutics, Inc. · Executive Compensation

Track SYRE — free
$99.23 +0.18 (+0.18%)
Market Cap
$8.72B
Shares
88.17M
Volume · Oct 28 722.56K Avg daily vol (3M) 1.21M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Cameron Turtle $6,707,361
Sheldon Sloan $2,211,805
Scott Burrows $2,192,045
Heidy King-Jones $2,192,045
Fiscal 2024
Executive Total
Sheldon Sloan $9,388,740
Cameron Turtle $6,960,186
Scott Burrows $2,207,366
Heidy King-Jones $2,051,909
Fiscal 2023
Executive Total
Cameron Turtle $15,919,545
Jonathan Alspaugh $8,360,029
Scott Burrows $7,551,539
Heidy King-Jones $6,588,281
Jeffrey M. Goldberg $830,207
Fiscal 2022
Executive Total
Anthony G. Quinn $2,392,254
Jeffrey M. Goldberg $1,832,485
Leslie Sloan $1,087,882
Jonathan Alspaugh $1,011,840
Jim Kastenmayer $865,785
Fiscal 2021
Executive Total
Anthony G. Quinn $2,623,186
Leslie Sloan $1,449,436

Executive changes

Person Change Filed
Laurie Stelzer Appointed 2026-05-29
Cameron Turtle Appointed 2026-05-29
Mark McKenna Appointed 2026-05-29
Peter Harwin Resigned 2026-05-29
Sandra Milligan, M.D., J.D. Appointed 2024-05-15
Mark McKenna Appointed 2024-02-05
Alison Lawton Resigned 2024-02-05
Laurie Stelzer Appointed 2023-11-28
Hunter Smith Resigned 2023-11-28
Jeffrey Albers Appointed 2023-11-28
Cameron Turtle Appointed 2023-11-28
Cameron Turtle Appointed 2023-11-28
Jeffrey Albers Appointed 2023-11-28
Laurie Stelzer Appointed 2023-11-28
Hunter C. Smith Resigned 2023-11-28
Ivana Magovčević-Liebisch Resigned 2023-11-28
Cameron Turtle Resigned 2023-11-28
Cameron Turtle Appointed 2023-11-28
Cameron Turtle Appointed 2023-11-28
Dr. Cameron Turtle Appointed 2023-10-10
Heidy Abreu King-Jones Appointed 2023-09-05
Scott Burrows Appointed 2023-09-05
Scott Burrows Appointed 2023-09-05
Scott Burrows Appointed 2023-09-05
Michael Henderson Appointed 2023-06-23

Leadership

Key facts CIK 1636282 CUSIP 00773J202 13F (30d) 27 filings 27 filers Visit website Investor relations